Introduction: CRISPR Reshaping U.S. Biotechnology
The U.S. CRISPR & Cas genes market was valued at USD 1.54 billion in 2024 and is projected to reach USD 8.29 billion by 2034, growing at a CAGR of 18.4%. This rapid expansion is fueled by groundbreaking applications in gene therapy, agriculture, drug discovery, and synthetic biology, where CRISPR...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek